About this trial
Single-port versus multi-port robotic surgery for rectal cancer
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Single-port robotic total mesorectal excision
Procedure/SurgerySingle-port robotic total mesorectal excision
Multi-port robotic total mesorectal excision
Procedure/SurgeryMulti-port robotic total mesorectal excision
Treatment groups
Trial outcomes
Primary outcomes
Incidence of perioperative complications
Perioperative complications will be described using the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTACAE) v. 4.03 criteria. Complications will refer to any medical occurrence directly attributed to the surgical procedure during and within the first 30 days.
Number of participants with conversion procedures
The number of patients converted from robotic to open or laparoscopic surgery
Secondary outcomes
Pain scores
Visual Analog Scale (VAS) pain scores for patients on postoperative days 1-3
Quality of specimen
As proposed and published by Quirke et al(Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002 Apr 1;20(7):1729-34.)
Total length of incisions
Total length of all abdominal incisions (measured in millimeters).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.